RESUMEN
To assess the efficacy of an original DAC-7 regimen: daunorubicine (DNR) 60 mg/m2/day, days 1-3; cytarabine (AraC) 200 mg/m2/day, days 1-7; cladribine (2-CdA) 5 mg/m2/day, days 1-5, 400 untreated adult acute myeloid leukemia patients (including 63 with preceding myelodysplastic syndrome), aged 45 (16-60) years were randomized to either DAC-7 (n=200) or DA-7 (without 2-CdA, n=200). The overall CR rate equaled 72% for DAC-7 and 69% for DA-7 arm (P=NS). After a single course of DAC-7 induction, the CR rate equaled 64% and was significantly higher compared to 47% in the DA-7 arm (P=0.0009). Median hospitalization time during the induction was 7 days shorter for DAC-7 compared to the DA-7 group (33 vs 40 days, P=0.002). Toxicity was comparable in both groups. The probability of 3-year leukemia-free survival (LFS) for DAC-7 and DA-7 group equaled 43 and 34%, respectively (P=NS). There was a trend toward higher LFS rate for patients aged >40 years receiving DAC-7 compared with DA-7 regimen (44 vs 28%, P=0.05). This study proves that addition of 2-CdA increases antileukemic potency of DNR+AraC regimen, thus resulting in a higher CR rate after one induction cycle when compared to DA-7, without additional toxicity. It shortens hospitalization time and may improve long-term survival in patients aged >40 years.
Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Leucemia Mieloide Aguda/tratamiento farmacológico , Adolescente , Adulto , Cladribina/administración & dosificación , Citarabina/administración & dosificación , Daunorrubicina/administración & dosificación , Femenino , Humanos , Leucemia Mieloide Aguda/mortalidad , Masculino , Persona de Mediana Edad , Resultado del TratamientoRESUMEN
The increased frequency of second malignancies in chronic lymphocytic leukaemia (CLL) is well known. Moreover, antineoplastic therapy additionally increases the risk of secondary cancers. In this study, we analysed whether treatment with cladribine (2-chlorodeoxyadenosine, 2-CdA) during the course of CLL had an impact on the subsequent occurrence of either secondary solid tumours or Richter's syndrome. There were 1487 eligible patients, 251 treated with 2-CdA alone, 913 treated with alkylating agents (AA)-based regimens alone and 323 treated with both 2-CdA and AA. Median time from the start of CLL treatment to the diagnosis of secondary malignancy was 1.9 years (0.5-5.1 years) for the 2-CdA group, 1.8 years (0.3-7.9 years) for the AA group and 3.9 years (0.3-8.4 years) for the 2-CdA+AA group. A total of 68 malignancies were reported in 65 patients. Ten events were non-melanotic skin cancers and were excluded from the analysis, leaving 58 events in 58 patients. In the group of patients treated with 2-CdA alone, there were 15 (6.0%) cases, in the group of patients treated with AA alone there were 26 (2.8%) cases, and in the group treated with 2-CdA+AA there were 17 (5.3%) cases of secondary malignancies. The differences between the frequency of secondary malignancies in the 2-CdA and 2-CdA+AA versus AA alone groups were not significant (P=0.05 and P=0.06, respectively). Only lung cancers occurred significantly more frequently in the 2-CdA (2.8%) and 2-CdA+AA (2.2%) treated groups compared with the AA patients (0.3%) (P<0.001 and P<0.01, respectively). In conclusion, 2-CdA in CLL patients does not seem to increase the risk of secondary malignancies except for lung cancers. However, further studies are necessary to establish the real risk of lung cancer in CLL patients treated with 2-CdA.
Asunto(s)
Antineoplásicos/uso terapéutico , Cladribina/uso terapéutico , Leucemia Linfocítica Crónica de Células B/tratamiento farmacológico , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Primarias Secundarias/tratamiento farmacológico , Adulto , Anciano , Anciano de 80 o más Años , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Ciclofosfamida/administración & dosificación , Doxorrubicina/administración & dosificación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prednisona/administración & dosificación , Estudios Retrospectivos , Síndrome , Vincristina/administración & dosificaciónRESUMEN
We analysed the treatment outcome of primary refractory HD patients managed with high-dose chemotherapy and haematopoietic cell transplantation. Data of 65 adult patients who underwent HDC/ASCT in nine Polish centres for primary resistant Hodgkin's disease between June 1991 and July 2000 were collected retrospectively. Response rate to HDC/ASC: CR, 54%; PR, 20%; less than PR, 15%; early deaths, 11%. Actuarial 3-year OS and PFS were 55% and 36%, respectively. In multivariate analysis, lack of bulky lymph nodes and use of immunotherapy were favourable factors for both OS and PFS. IPF <3 at the time of transplantation was predictive for PFS. However, the prognostic impact of immunotherapy should be interpreted with caution since this group included more patients who achieved CR after HDC/ASCT. The results of HDC/ASCT are encouraging and confirm earlier findings. The role of immunotherapy should be further investigated in prospective trials.
Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Trasplante de Células Madre Hematopoyéticas/mortalidad , Enfermedad de Hodgkin/terapia , Adolescente , Adulto , Análisis de Varianza , Niño , Femenino , Enfermedad de Hodgkin/mortalidad , Humanos , Inmunoterapia , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos , Terapia Recuperativa , Análisis de Supervivencia , Tasa de Supervivencia , Trasplante Autólogo/mortalidad , Resultado del TratamientoRESUMEN
False positivity of the NBT test in neoplastic diseases described by some authose may be a limitation in the use of the test for infection screening in cancer patients. For explaining this problem studies were performed in a group of 30 patients with various untreated malignancies without infection and in 20 of these with bacteriologically confirmed infections. The obtained results were compared with those in groups of normal persons without and with infection. Slightly modified Park method for spontaneous and stimulated NBT test was used. No significant differences between patients of both groups without infection were found. The increase in positivity of the test in presence of infection was lower in cancer patients than in normal subjects, however, it was non-significant. We did not observe any false-positive results in our patients, though one case of false negativity in myeloma is described separately. It is concluded that neoplastic disease does not cause, as such positivity of the NBT test. Because of similar response of NBT test to presence of infection, the NBT test is recognized as very useful for infection screening in cancer patients similarly as in normal persons.
Asunto(s)
Infecciones Bacterianas/diagnóstico , Neoplasias/complicaciones , Nitroazul de Tetrazolio , Sales de Tetrazolio , Adulto , Anciano , Infecciones Bacterianas/complicaciones , Ensayos Clínicos como Asunto , Infecciones por Escherichia coli/diagnóstico , Estudios de Evaluación como Asunto , Humanos , Persona de Mediana Edad , Infecciones Neumocócicas/diagnóstico , Infecciones por Proteus/diagnóstico , Infecciones Estafilocócicas/diagnóstico , Infecciones Estreptocócicas/diagnósticoRESUMEN
As the first step in the study, the results of the NBT test in 83 patients with various untreated neoplasms, including 20 lymphomas, without bacterial infections and in 35 neoplastic patients with this complications were compared with the results obtained in control groups. No significant differences in the results were found between the groups of neoplastic patients without or with bacterial infections and the controls. To evaluate the NBT test during radio- and/or chemotherapy, especially in neutropenia, 45 patients were NBT-monitored. During the study of 102 episodes of neutropenia 43 infections occurred and 30 were NBT-confirmed. In remaining 13 cases it was impossible to perform the test because of extremely low neutrophil count (below 500/mul). All 20 infections in patients with normal neutrophil count were NBT-positive. These results confirm the usefulness of the test for infection screening in untreated with malignancies, as well as in patients receiving radio- and/or chemotherapy. However, the test can be taken only in patients without severe neutropenia.
Asunto(s)
Infecciones Bacterianas/diagnóstico , Neoplasias/complicaciones , Nitroazul de Tetrazolio , Sales de Tetrazolio , Antineoplásicos/efectos adversos , Humanos , Neoplasias/tratamiento farmacológico , Neoplasias/radioterapia , Neutropenia/complicaciones , Neutropenia/etiología , Radioterapia/efectos adversosRESUMEN
Hemorheological disturbances in patients with monoclonal gammapathies are widely known, but there is little information about microcirculation in these patients. The following study was performed to examine skin microcirculation and its relationship with blood rheology. We analysed both haematological and hemorheological parameters (blood and plasma viscosity, aggregation index and filterability of 1 ml of whole blood) and skin microcirculation in 46 patients with monoclonal gammapathy and 22 healthy controls. Microcirculation on dorsal aspect of the hand was examined with laser Doppler flowmeter. We measured resting flow and biological zero and maximal flow during postischemic hyperaemic reaction after one minute occlusion on the arm. The same parameters were estimated for CMBC (concentration of moving blood cells). Patients with monoclonal gammapathy are characterised by statistically higher whole blood and plasma viscosities and other hemorheological parameters and disturbed skin microcirculation expressed as statistically significant lower resting flux and impaired reaction for temporary occlusion.
Asunto(s)
Hemorreología , Paraproteinemias/sangre , Piel/irrigación sanguínea , Adulto , Anciano , Anciano de 80 o más Años , Proteínas Sanguíneas/análisis , Viscosidad Sanguínea , Agregación Eritrocitaria , Deformación Eritrocítica , Femenino , Hematócrito , Humanos , Inmunoglobulinas/análisis , Flujometría por Láser-Doppler , Linfoma/sangre , Masculino , Microcirculación , Persona de Mediana Edad , Mieloma Múltiple/sangre , Paraproteínas/análisis , Macroglobulinemia de Waldenström/sangreRESUMEN
PIP: 26 women using Ovosiston as a contraceptive and 22 women using it as a therapeutic agent were administered thromboelastograms during the 1st and 2nd halves of the menstrual cycle. Results were compared with those taken from 20 healthy women. A significant increase in the maximal elasticity of the clot in the 2nd half of the cycle was revealed in those using Ovosiston as a contraceptive as compared with the control group. Those using Ovosiston as a therapeutic agent for hypothrombosis showed a normalization of the thromboelastographic patterns of blood clotting.^ieng
Asunto(s)
Acetato de Clormadinona/farmacología , Mestranol/farmacología , Tromboelastografía , Acetato de Clormadinona/uso terapéutico , Anticonceptivos Orales/farmacología , Femenino , Humanos , Mestranol/uso terapéutico , Trombosis/prevención & controlRESUMEN
UNLABELLED: Among 149 patients with recently recognized plasma cell dyscrasia (PCD) in years 1994-2000 72 persons with serologically and nephrologically documented diagnostic profile were selected. In this group of pts we assessed dependence between degree of reduced glomerular filtration rate (GFR), evaluated by serum creatinine concentration and calculated with Barasckay's formula and hypercalcemia, hyperuricemia as well as type of monoclonal protein in urine. RESULTS: We revealed statistically significant higher values of calcium (p = 0.005), uric acid (p = 0.000001) concentrations and higher occurrence of Bence-Jones proteinuria (mainly kappa) in 22 patients with serum creatinine > 1.5 mg/dl in comparison with 50 patients with serum creatinine < or = 1.5 mg/dl. Among 72 patients, GFR > 90 ml/min, calculated with Barasckay's formula, was stated only in 9 patients (12.5%). There was no difference in nephrotoxity between kappa and lambda light chains with reference to serum creatinine concentration and GFR. The group of 12 patients with light chain dyscrasia (LCD) had higher degree of nephrotoxicity in comparison with other forms of PCD. On the basis of our study we concluded that patients with clinical suspicion of PCD, especially those with LCD are referred to a special Protein Laboratory too late, it means at the time of significant nephrological risk in the form of low glomerular filtration rate, hypercalcemia and hyperuricemia.
Asunto(s)
Enfermedades Renales/etiología , Paraproteinemias/complicaciones , Adulto , Anciano , Anciano de 80 o más Años , Proteína de Bence Jones/orina , Creatinina/sangre , Femenino , Tasa de Filtración Glomerular , Humanos , Hipercalcemia/diagnóstico , Hipercalcemia/etiología , Inmunoglobulinas/orina , Enfermedades Renales/diagnóstico , Enfermedades Renales/fisiopatología , Masculino , Persona de Mediana Edad , Paraproteinemias/diagnóstico , Paraproteinemias/fisiopatología , Medición de Riesgo , Ácido Úrico/sangreRESUMEN
The quality of life (QL) in 90 male patients (age 41.2 +/- 41) suffering from Ist IInd hemodynamic WHO-stage of essential arterial hypertension has been studied during 3 months therapy. The patients have been divided into 3 groups treated with enalapril, atenolol and verapamil respectively. The Sickness Impact Profile, Bulpitt's test and Spitzer's test were used for evaluation of QL. Significant reduction in diastolic arterial blood pressure has been achieved during the treatment period. In the same time improvement in QL indices was observed, most evident in group of enalapril, moderate in group of verapamil and the minor in atenolol group. It is concluded that these three QL test (SIP, Bulpit, Spitzer) are very useful in monitoring of treatment of the essential arterial hypertension.
Asunto(s)
Hipertensión/tratamiento farmacológico , Calidad de Vida , Adulto , Antihipertensivos/uso terapéutico , Atenolol/uso terapéutico , Enalapril/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Verapamilo/uso terapéuticoRESUMEN
The estimation of microcirculatory parameters in patients with essential hypertension and in normotensic control group was the aim of this study. The study group consisted of 14 patients with essential hypertension confirmed by 24-hours ABP. 10 healthy patients served as control group. The flow in the skin microcirculation was measured by laser-Doppler flowmeter (PF-3, PERIMED) on dorsal part of the palm. Microcirculatory indices were registered in resting conditions, during one-minute occlusion reaction and during reactive hyperemia. The following indices were calculated: resting flow, biological zero, maximal flow, time to maximal flow, ratio of maximal to resting flow, ratio of resting flow to biological zero and ratio of maximal flow to biological zero. Skin microcirculation was highly disturbed in patients with essential hypertension. It was expressed by significantly higher biological zero and longer time to maximal flow.
Asunto(s)
Hipertensión/diagnóstico , Flujometría por Láser-Doppler/métodos , Piel/irrigación sanguínea , Adulto , Femenino , Humanos , Masculino , Microcirculación , Persona de Mediana EdadRESUMEN
Isolated abdominal lymphadenopathy is not such a common but a real diagnostic problem. Widespread prevalence of ultrasonography in routine diagnostics has been contributed to its greater recognition. In the first part of the article examinations which lead to the diagnosis (such as: microbiological examination, ultrasonography, CT, MRI, lymphography, histopathological examination) are discussed basing on the literature. The potential etiology of abdominal lymphadenopathy is described in the second part of the article. The characteristic changes are discussed for mentioned disease entities.
Asunto(s)
Enfermedades Linfáticas/patología , Abdomen/patología , HumanosRESUMEN
Bone marrow transplantation is connected with many psychological problems of the patient determined mainly by the procedure itself. In individual phases of bone marrow transplantation (qualification of patients for operation, peritransplantation and post-transplantation periods, and final phase) different disturbances and difficulties are seen. Own observations as well as the literature data indicate the need of full diagnosis and psychotherapy, and sometimes even of psychiatric intervention during that method of treatment.
Asunto(s)
Trasplante de Médula Ósea/psicología , HumanosRESUMEN
Acquired pure red cell aplasia is rare disorder of hematopoiesis. Because of the variety of reasons for PRCA optimal treatment is based on highly specialistic diagnostics. Both humoral and cellular mechanisms are involved in the pathogenesis of PRCA. Corticosteroids, cyclosporin A, high-dose intravenous immunoglobulin therapy are recommended in PRCA. Treatment failures may be successfully managed with antihuman thymocyte globulin, cyclophosphamide or azathioprine. We describe also the lots of five patients with this disorder.
Asunto(s)
Aplasia Pura de Células Rojas/diagnóstico , Aplasia Pura de Células Rojas/terapia , Adolescente , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Aplasia Pura de Células Rojas/etiologíaRESUMEN
The main problems and difficulties in transplantation of haematogenous stem cells are discussed. The problems include: organization of a team of specialists and bone marrow transplantation centre, preparation of the recipient (patient) complications connected with preparation for transplantation, graft taking, graft versus host disease, recurrence of the underlying disease. In the analysis only those patients (8 cases) are included who had received marrow transplantation after chemotherapeutic-radiotherapeutic preparation (3 patients are alive). The first experiences are described also with three autotransplantations of haematogenous stem cells obtained by means of cell separator from peripheral blood. These experiences indicate that it is possible in our country to carry out this highly sophisticated method which requires, however, further improvements and ensuring of adequate personnel and equipment.